HomeELYM • NASDAQ
add
Eliem Therapeutics Inc
Previous close
$8.18
Day range
$7.76 - $8.61
Year range
$2.34 - $11.55
Market cap
231.36M USD
Avg Volume
1.80M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.00M | -60.72% |
Net income | -1.70M | 92.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 105.03M | -3.97% |
Total assets | 109.33M | -10.44% |
Total liabilities | 2.95M | -43.54% |
Total equity | 106.38M | — |
Shares outstanding | 29.09M | — |
Price to book | 2.13 | — |
Return on assets | -6.84% | — |
Return on capital | -7.00% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.70M | 92.39% |
Cash from operations | -1.82M | 88.01% |
Cash from investing | 13.75M | 137.21% |
Cash from financing | 15.00K | 1,400.00% |
Net change in cash | 11.92M | 230.29% |
Free cash flow | -2.39M | -158.68% |
About
Founded
2018
Headquarters
Website
Employees
10